• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Manhattan Labs

Anonymous board for Manhattan Labs
Replies
67
Views
24K
anonymous
Replies
614
Views
121K
anonymous
Replies
6
Views
4K
anonymous
Replies
8
Views
6K
anonymous
Replies
171
Views
49K
anonymous
Replies
42
Views
17K
Anonymous
Replies
107
Views
42K
Anonymous
Replies
2
Views
3K
Anonymous
Replies
1
Views
3K
Anonymous
Replies
2
Views
3K
Anonymous
Replies
5
Views
4K
Anonymous
Replies
14
Views
4K
Anonymous
Replies
14
Views
6K
Anonymous
Replies
13
Views
5K
Anonymous
KC
Replies
7
Views
5K
Anonymous
Replies
3
Views
4K
Anonymous
Replies
14
Views
9K
Anonymous
Replies
19
Views
7K
Anonymous
Replies
17
Views
6K
Anonymous
Replies
0
Views
3K
Anonymous